Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON49534
NL-OMON49534
Completed
Phase 2

18F-PSMA-1007 PET to detect primary prostate cancer: a comparative study with mpMRI and correlation to histopathology - 18F-PSMA PET in primary prostate cancer

Radboud Universitair Medisch Centrum0 sites75 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Radboud Universitair Medisch Centrum
Enrollment
75
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • •\- Suspicion for prostate cancer (e.g. elevated PSA, suspicious rectal
  • •examination)
  • •\- Males \>\= 18 years

Exclusion Criteria

  • •\- Prostate biopsy in the last 6 months
  • •\- History of prostate cancer
  • •\- Second active malignancy
  • •\- Contra\-indications for mpMRI or PET: claustrophobia or inability to lay still
  • •for the duration of the exam.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, Not Recruiting
Phase 1
18F-PSMA PET in primary prostate cancer.75 patients with the suspicion on PCa (elevated PSA and/or abnormal digital rectal exam) will receive a PSMA-PET following mpMRI. 25 patients with PIRADS 1-2 (probably benign disease), 25 patients with PIRADS 3 (equivocal disease) and 25 patients with PIRADS 4-5 (highly suspicious for malignancy) will be included in this explorative study.MedDRA version: 20.0Level: LLTClassification code 10036921Term: Prostate carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10060862Term: Prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2020-001387-28-NLRadboud University Medical Center75
Active, Not Recruiting
Phase 1
PSMA-PET/CT for prostate cancer
EUCTR2017-003461-96-BEGhent University Hospital72
Recruiting
N/A
PSMA PET prostate cancer registration studyProstate cancer
NL-OMON28640-
Completed
Phase 1
18F-PSMA-1007 PET Imaging to Detect Primary Prostate CancerProstate Cancer
NCT04487847Radboud University Medical Center75
Not Yet Recruiting
N/A
Prostate Cancer 18F-PSMA-1007 PET/CT Access TrialProstate Cancer
NCT06489496Alberta Health services1,000